Semaglutide,
on the record.
GLP-1 agonist·Live
GLP-1 receptor agonist for chronic weight management and type 2 diabetes.
Also known as
Ozempic · Wegovy · Rybelsus
01
The evidence.
9 PubMed
0 ClinicalTrials.gov
0 openFDA
90-day search interest
PubMed·Dec 1, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Johansson E, Wilding JPH, Upadhyay N et al.
PubMed·Jul 1, 2026
Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.
Long W, Ningning L, Weijun H
PubMed·Jul 1, 2026
Correction: Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.
Ishiguro M, Nishimura R
PubMed·Jun 1, 2026
Photodistributed exfoliative dermatitis associated with semaglutide: Expanding the spectrum of glucagon-like peptide-1 receptor agonist-associated cutaneous reactions.
Kann R, Weitzner Y, Tan C et al.
PubMed·Jun 1, 2026
Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis.
Rao H, Kumar S, Ali SME et al.
PubMed·Jun 1, 2026
Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.
Strathe A, Bomberg EM, Jensch G et al.
PubMed·Jun 1, 2026
Met@MPDA rejuvenates BMSC energy metabolism to promote bone regeneration in semaglutide-treated obese periodontitis.
Jiang T, Wan TH, Wang MJ et al.
PubMed·May 25, 2026
The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials.
Trott M, Arnautovska U, Johnston D et al.
PubMed·May 25, 2026
To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications.
Peary A, Vaidya N, Jakicic J et al.
02
How you get it.
Step 1
Quick intake
Five-minute medical questionnaire.
Step 2
MD review
Asynchronous review by a licensed physician.
Step 3
Photo + ID
Weight and ID photo, securely uploaded.
Step 4
Rx ships
Cold-chain shipped, refilled monthly.
SemaglutideGLP-1 agonist
Start intake